Zengqiang Qu

751 total citations
19 papers, 567 citations indexed

About

Zengqiang Qu is a scholar working on Oncology, Hepatology and Surgery. According to data from OpenAlex, Zengqiang Qu has authored 19 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Hepatology and 5 papers in Surgery. Recurrent topics in Zengqiang Qu's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Mechanisms and Therapy (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Zengqiang Qu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Mechanisms and Therapy (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Zengqiang Qu collaborates with scholars based in China and Ireland. Zengqiang Qu's co-authors include Jian Zhai, Xianling Guo, Kai Sun, Qiudong Zhao, Xue Zhao, Mengchao Wu, Zhigang Fu, Feng Shen, Lixin Wei and Jianrui Song and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Zengqiang Qu

18 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zengqiang Qu China 9 261 188 167 167 114 19 567
Quentin Bayard France 9 302 1.2× 245 1.3× 162 1.0× 185 1.1× 105 0.9× 13 630
Funan Qiu China 12 239 0.9× 241 1.3× 91 0.5× 183 1.1× 126 1.1× 32 593
Hamza Chettouh France 6 233 0.9× 112 0.6× 90 0.5× 110 0.7× 82 0.7× 7 421
Norikazu Takemoto Japan 9 280 1.1× 139 0.7× 147 0.9× 163 1.0× 115 1.0× 12 519
Liangcai Wu China 15 277 1.1× 200 1.1× 89 0.5× 81 0.5× 166 1.5× 24 635
T Maass Germany 15 388 1.5× 133 0.7× 229 1.4× 176 1.1× 112 1.0× 25 720
Lantian Tian China 11 301 1.2× 218 1.2× 61 0.4× 125 0.7× 128 1.1× 21 549
Zhi-Qiang Meng China 12 214 0.8× 126 0.7× 77 0.5× 97 0.6× 213 1.9× 16 483
Herman Wong Hong Kong 8 187 0.7× 111 0.6× 225 1.3× 424 2.5× 162 1.4× 14 654
Wenbing Sun China 14 226 0.9× 189 1.0× 126 0.8× 240 1.4× 121 1.1× 25 602

Countries citing papers authored by Zengqiang Qu

Since Specialization
Citations

This map shows the geographic impact of Zengqiang Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zengqiang Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zengqiang Qu more than expected).

Fields of papers citing papers by Zengqiang Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zengqiang Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zengqiang Qu. The network helps show where Zengqiang Qu may publish in the future.

Co-authorship network of co-authors of Zengqiang Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Zengqiang Qu. A scholar is included among the top collaborators of Zengqiang Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zengqiang Qu. Zengqiang Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Li, Xiaowei, Zhigang Fu, Xiaoxia Chen, et al.. (2025). Vascular stent graft for the treatment of post-pancreaticoduodenectomy hemorrhage and risk factors for rebleeding. Pancreatology. 25(3). 396–404. 1 indexed citations
2.
Li, Xiaowei, Zhigang Fu, Xiaoxia Chen, et al.. (2025). Clinical Outcomes of Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab for Treating Hepatocellular Carcinoma and Type IV Portal Vein Tumor Thrombus. Journal of Hepatocellular Carcinoma. Volume 12. 169–182.
3.
Li, Xiaowei, Zhigang Fu, Xiaoxia Chen, et al.. (2022). Efficacy and Safety of Lenvatinib Combined With PD-1 Inhibitors Plus TACE for Unresectable Hepatocellular Carcinoma Patients in China Real-World. Frontiers in Oncology. 12. 950266–950266. 29 indexed citations
4.
Zhai, Jian, Jianwei Liu, Zhigang Fu, et al.. (2022). Comparison of the safety and prognosis of sequential regorafenib after sorafenib and lenvatinib treatment failure in patients with unresectable hepatocellular carcinoma: a retrospective cohort study. Journal of Gastrointestinal Oncology. 13(3). 1278–1288. 6 indexed citations
5.
Xue, Feng, Jian Zhai, Jianwei Liu, et al.. (2022). Efficacy and safety of second-line regorafenib after sorafenib or lenvatinib first line in patients with unresectable hepatocellular carcinoma: A real-world study.. Journal of Clinical Oncology. 40(16_suppl). e16125–e16125. 2 indexed citations
6.
Li, Xiaowei, Zhigang Fu, Xiaoxia Chen, et al.. (2022). Coexistence of situs inversus totalis and hepatocellular carcinoma: A series of nine cases and a literature review. SHILAP Revista de lepidopterología. 5(1). 46–49. 1 indexed citations
7.
Fu, Zhigang, Xiaowei Li, Xiaoxia Chen, et al.. (2021). Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study. Hepatology International. 15(3). 663–675. 122 indexed citations
8.
Zhang, Qun, Zengqiang Qu, Jin Zhou, et al.. (2021). In vitro study on the effect of cornin on the activity of cytochrome P450 enzymes. BMC Complementary Medicine and Therapies. 21(1). 138–138. 1 indexed citations
9.
Liu, Chao, Zengqiang Qu, Lijun Zhu, et al.. (2021). Design, synthesis, and anti-tumor activities of novel Brevinin-1BYa peptidomimetics. Bioorganic & Medicinal Chemistry Letters. 37. 127831–127831. 4 indexed citations
10.
Ding, Ning, et al.. (2021). Incidence and Risk Factors of Contrast Nephropathy After Tace In Patients with Liver Cancer and Chronic Kidney Disease. Clinical and investigative medicine. 44(3). E19–E24. 1 indexed citations
11.
Zhai, Jian, Shuping Qu, Xiaowei Li, et al.. (2015). miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 464(1). 161–167. 39 indexed citations
12.
Mu, Wenjing, Chaobo Hu, Haibin Zhang, et al.. (2015). miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression. Cell Research. 25(4). 477–495. 77 indexed citations
13.
Kong, Feifei, Zengqiang Qu, Haihua Yuan, et al.. (2014). Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer. Oncology Reports. 31(6). 2660–2668. 75 indexed citations
14.
Ren, Zhenggang, Kangshun Zhu, Min-qiang Lu, et al.. (2012). A randomized controlled phase II study of the prophylactic effect of urea-based cream on the hand-foot skin reaction associated with sorafenib in advanced hepatocellular carcinoma.. Journal of Clinical Oncology. 30(15_suppl). 4008–4008. 21 indexed citations
15.
Qu, Zengqiang, Xiaodong Li, Ping He, et al.. (2011). Phenacetin O-Deethylation is a Useful Tool for Evaluation of Hepatic Functional Reserve in Rats with CCl4-Induced Chronic Liver Injury. Journal of Surgical Research. 175(2). e61–e66. 2 indexed citations
16.
Yi, Bin, Ai‐Min Xu, Eric C. H. Lai, et al.. (2011). Preoperative portal vein embolization for hilar cholangiocarcinoma--a comparative study.. PubMed. 57(104). 1341–6. 13 indexed citations
17.
Wang, Xiangrui, Zengqiang Qu, Xiaodong Li, et al.. (2009). Activity of sulfotransferase 1A1 is dramatically upregulated in patients with hepatocellular carcinoma secondary to chronic hepatitis B virus infection. Cancer Science. 101(2). 412–415. 12 indexed citations
18.
Song, Jianrui, Zengqiang Qu, Xianling Guo, et al.. (2009). Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells. Autophagy. 5(8). 1131–1144. 159 indexed citations
19.
Qu, Zengqiang, Guojun Qian, & Han Chen. (2002). Therapeutic effect of transcatheter arterial chemoembolization combined with percutaneous ethanol injection in hepatocellular carcinoma. The Chinese-German Journal of Clinical Oncology. 1(1). 28–29. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Quentin Bayard Breakdown of academic impact, for papers by Funan Qiu Breakdown of academic impact, for papers by Hamza Chettouh Breakdown of academic impact, for papers by Norikazu Takemoto Breakdown of academic impact, for papers by Liangcai Wu Breakdown of academic impact, for papers by T Maass Breakdown of academic impact, for papers by Lantian Tian Breakdown of academic impact, for papers by Zhi-Qiang Meng Breakdown of academic impact, for papers by Herman Wong Breakdown of academic impact, for papers by Wenbing Sun
Rankless by CCL
2026